Therapeutic Implications of the Use of Colon ODX in
Stage II and III Disease Norman Wolmark, MD Chairman and Principal Investigator of the National Surgical Adjuvant Breast and Bowel Project (NSABP), Professor and Chairman of Human Oncology, Drexel University School of Medicine Philadelphia, Pennsylvania אינך רואה את ההרצאה?, לחץ כאן |
| |

Therapeutic Implications of the Use of Colon ODX in
Stage II and III Disease